Details for 2013158781

Up to date per 02.04.2026

Actions

Title / Product Name

Orale transmukosale Dosierungsformen mit Sufentanil und Triazolam

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2013158781

EP Publication Number

2604257

E-Number

904258

Language

PCT Number

Publication Date

19.06.2013 A

28.06.2017 B1

Registration Date

28.06.2017

AT Publication Date

15.07.2017

Application Date

07.08.2008

Registration Number

Priorities

07.08.2007

954501 P

IPC

A61K 9/70 20060101AFI20161216BHEP

Maximum Duration of Protection

07.08.2028

Owner

Acelrx Pharmaceuticals, Inc.575 Chesapeake Drive Redwood City, CA 94063US

Representative

No representatives present

Inventor

Palmer, Pamela140 Vasquez Avenue San Francisco, CA California 94127US

Tzannis, Stelios35241 Wycombe Place Newark, CA California 94560US

Schreck, Thomas140 Willowbrook Drive Portola Valley, CA California 94028US